Head: Prof. Dr. Wolfgang Hammerschmidt

The independent Research Unit Gene Vectors (AGV) investigates the Epstein Barr Virus (EBV) and its interaction with human B-cells, in particular in the infection and transformation of the target cells to tumor cells or cells, which proliferate indefinitely. The aim of this research is to achieve a detailed understanding of the EBV infection in the development of tumors and to put these insights to medical use in the shape of a unique model system.

To the AGV website

Head: Dr. Vigo Heissmeyer

The Reserarch Unit Molecular Immunoregulation (AMIR), headed up by Dr. Vigo Heissmeyer, is part of the Institute of Molecular Immunology. AMIR investigates the molecular programming of T-cell tolerance, inter alia at the level of posttranscriptional gene regulation. The aim of AMIR is to achieve a better understanding of the molecular programs of T-cells, which make a distinction between the body’s own structure and foreign structures possible. The research focus is on autoimmune diseases such as type 1 diabetes and Lupus erythematodes.

To the AMIR website

Director: Prof. Dr. Jörg Durner
Chair of Biochemical Plant Pathology at Technische Universität München

The Institute of Biochemical Plant Pathology (BIOP) explores defense mechanisms, growth and fitness of plants in response to environmental cues, with a focus on molecular mechanisms that allow plants to respond to biotic and abiotic factors. The aim of this research is to find new procedures for sustainable agriculture and biotechnological use of plants, as well as to contribute to safeguarding the role of plants in the nourishment and health of human beings.
BIOP is a part of the Department of Environmental Sciences (DES). BIOP includes the Research Unit Environmental Engineering (EUS).

To the BIOP website

Director: Prof. Dr. Robert Schneider

The Institute of Functional Epigenetics (IFE) is interested in how genes are packaged within the nucleus of a cell. The focus is on the so-called "histone proteins" on which the DNA strands are wound and that can determine whether a gene can be read or not. In addition, we are examining the connections between common diseases and distortions in DNA packing.

To the IFE website

Director: Prof. Dr. Oliver Plettenburg
Institute of Organic Chemistry at Leibniz Universität Hannover

The Institute for Medicinal Chemistry (IMC) undertakes research into the chemical properties of new and old active substances, as well as the development of innovative therapeutic methods. The institute, based in Hanover, is an external facility of the Helmholtz Zentrum München and is operated in co-operation with the Leibniz University Hanover.

To the IMC website

Director: Prof. Dr. Stephanie Combs
Chair of Radiation Oncology at Technische Universität München

The Institute of Radiation Medicine (IRM) is a part of the Department of Radiation Sciences (DRS) of the Helmholtz Zentrum München (HMGU). The Institute has a strong link to the Department of Radiation Oncology at the Klinikum rechts der Isar, Technische Universität München (TUM). The main focus is clinically oriented research related to technical and biological issues of radiation therapy. This involves research in preclinical radio- and molecular biology, imaging, as well as new technical developments in radiation technology, and provides a solid basis to bridge the gap between the basic and pre-clincial programmes of the DRS members.

To the IRM website

Director: Prof. Dr. Martin Göttlicher
Chair of Toxicology and Environmental Hygiene at Technische Universität München

The Institute of Molecular Toxicology and Pharmacology (TOXI) investigates the cellular response pathways and genetic foundations with which the organism reacts to chemical substances.. The aim of this research is to achieve a better understanding of  the role of these mechanisms in the etiology and progression of complex diseases and to reduce health risks. This leads to the development of approaches for the prevention of environmentally related diseases and for innovative therapeutic concepts. TOXI includes the Research Unit Cellular Signal Integration (AZS).

To the TOXI website

Head: Dr. Daniel Krappmann

The Research Unit Cellular Signal Integration (AZS) at the Institute of Molecular Toxicology and Pharmacology (TOXI)  conducts research for a better understanding of cellular response pathways. In doing so, it focuses on the interaction of proteins complexes and the effects of posttranslational modifications. The aim of this research is to understand the faulty regulation of the signal complexes in the immune system in cas

To the AZS website

Director: Prof. Dr. Ulrike Protzer
E-mail
Chair of Virology at Technische Universität München

The Institute of Virology (VIRO) investigates viruses that can cause chronic infections life-threatening diseases in humans. The research focus is on the AIDS virus (HIV), on endogenous retroviruses that are integrated into our germline, and on hepatitis B and C viruses, which cause liver cirrhosis and hepatocellular carcinoma.  Molecular studies identify new diagnostic and therapeutic concepts to prevent and treat these viral diseases or to prevent the development of virus-induced tumors.

to the VIRO website